CIK 0001937653 · Non-accelerated filer<br>Smaller reporting company
Zymeworks Inc.
Sign in to watch- Ticker
- ZYME
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 883099146
- Phone
- 302-274-8744
- Business address
- 108 PATRIOT DRIVE, SUITE A, MIDDLETOWN, DE, 19709
- Former names
- Zymeworks Delaware Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $357,557
- in 1 filing
Net −$357,557. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-01-05 | Moore Paul Andrew Chief Scientific Officer | Option exercise · Restricted Stock Unit | −17,166 | 34,334 | ||
| 2024-01-05 | Moore Paul Andrew Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2024-01-05 | Moore Paul Andrew Chief Scientific Officer | Grant or award · Restricted Stock Unit | +60,000 | 60,000 | ||
| 2024-01-05 | Smith Jeffrey T L EVP & Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +90,000 | 90,000 | ||
| 2024-01-05 | Smith Jeffrey T L EVP & Chief Medical Officer | Grant or award · Restricted Stock Unit | +60,000 | 60,000 | ||
| 2023-12-26 | EcoR1 Capital, LLC 10% owner | Purchase · Pre-Funded Warrants | +5,086,521 | $9.83 | $50.0M | 5,086,521 |
| 2023-12-26 | EcoR1 Capital, LLC 10% owner | Purchase · Pre-Funded Warrants | +5,086,521 | $9.83 | $50.0M | 5,086,521 |
| 2023-12-11 | Astle Christopher SVP & Chief Financial Officer | Option exercise | +1,550 | 2,883 | ||
| 2023-12-11 | Astle Christopher SVP & Chief Financial Officer | Sale | −886 | $9.13 | $8K | 1,997 |
| 2023-12-11 | Astle Christopher SVP & Chief Financial Officer | Option exercise · Restricted Stock Unit | −1,550 | 0 | ||
| 2023-12-07 | Campoy Carlos Director | Grant or award · Stock Option (Right to Buy) | +37,000 | 37,000 | ||
| 2023-12-07 | RENTON HOLLINGS Director | Grant or award · Stock Option (Right to Buy) | +37,000 | 37,000 | ||
| 2023-12-07 | Neu Kelvin Director | Grant or award · Stock Option (Right to Buy) | +37,000 | 37,000 | ||
| 2023-12-07 | Cox Troy Director | Grant or award · Stock Option (Right to Buy) | +37,000 | 37,000 | ||
| 2023-12-07 | Mahony Susan Director | Grant or award · Stock Option (Right to Buy) | +37,000 | 37,000 | ||
| 2023-12-07 | Miller Derek John Michael Director | Grant or award · Stock Option (Right to Buy) | +37,000 | 37,000 | ||
| 2023-12-07 | Davidson Nancy Director | Grant or award · Stock Option (Right to Buy) | +74,000 | 74,000 | ||
| 2023-12-07 | Hillan Kenneth J. Director | Grant or award · Stock Option (Right to Buy) | +37,000 | 37,000 | ||
| 2023-06-30 | Campoy Carlos Director | Grant or award · Stock Option (Right to Buy) | +50,000 | 50,000 | ||
| 2023-06-16 | EcoR1 Capital, LLC 10% owner | Purchase | +3,350,000 | $8.12 | $27.2M | 13,437,473 |
Page 9 of 12 · 224 trades